Sökning: WFRF:(Andreasson Ulf) >
Longitudinal minima...
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission : results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
-
- Schmitz, Alexander (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ Hosp, Denmark
-
- Brondum, Rasmus Froberg (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ Hosp, Denmark
-
- Johnsen, Hans Erik (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ Hosp, Denmark; Aalborg Univ, Denmark; Nordic Myeloma Study Grp NMSG, Sweden
-
visa fler...
-
- Mellqvist, Ulf-Henrik (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; South Elvsborg Hosp, Sweden
-
- Waage, Anders (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Norwegian Univ Sci & Technol, Norway; St Olavs Univ Hosp, Norway
-
- Gimsing, Peter (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Univ Copenhagen, Denmark
-
- Bruinink, Davine Hofste Op (författare)
- Erasmus MC, Netherlands
-
- van der Velden, Vincent (författare)
- Erasmus MC, Netherlands
-
- van der Holt, Bronno (författare)
- Erasmus MC, Netherlands; Erasmus MC Canc Inst, Netherlands
-
- Hansson, Markus (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Skane Univ Hosp, Sweden
-
- Andersen, Niels Frost (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Aarhus Univ Hosp, Denmark
-
- Frolund, Ulf Christian (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Sjllands Univ Hosp, Denmark
-
- Helleberg, Carsten (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Herlev Hosp, Denmark
-
- Schjesvold, Fredrik H. (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Oslo Univ Hosp, Norway; Univ Oslo, Norway
-
- Ahlberg, Lucia (författare)
- Region Östergötland, Hematologiska kliniken US,Nordic Myeloma Study Grp NMSG, Sweden
-
- Gulbrandsen, Nina (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Oslo Univ Hosp, Norway; Univ Oslo, Norway
-
- Andreasson, Bjorn (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; NU Hosp Grp, Sweden
-
- Lauri, Birgitta (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Sunderby Hosp, Sweden
-
- Haukas, Einar (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Stavanger Univ Hosp, Norway
-
- Bodker, Julie Stove (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ Hosp, Denmark
-
- Roug, Anne Stidsholt (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ, Denmark
-
- Bogsted, Martin (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ Hosp, Denmark; Aalborg Univ, Denmark
-
- Severinsen, Marianne T. (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ, Denmark
-
- Gregersen, Henrik (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ, Denmark; Nordic Myeloma Study Grp NMSG, Sweden
-
- Abildgaard, Niels (författare)
- Nordic Myeloma Study Grp NMSG, Sweden; Odense Univ Hosp, Denmark
-
- Sonneveld, Pieter (författare)
- Erasmus MC, Netherlands; European Myeloma Network EMN, Denmark
-
- Dybkaer, Karen (författare)
- Aalborg Univ Hosp, Denmark; Aalborg Univ Hosp, Denmark; Aalborg Univ, Denmark
-
visa färre...
-
(creator_code:org_t)
- 2022-02-05
- 2022
- Engelska.
-
Ingår i: BMC Cancer. - : BMC. - 1471-2407. ; 22:1
- Relaterad länk:
-
https://liu.diva-por... (primary) (Raw object)
-
visa fler...
-
https://bmccancer.bi...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Multiple myeloma remains an incurable disease with multiple relapses due to residual myeloma cells in the bone marrow of patients after therapy. Presence of small number of cancer cells in the body after cancer treatment, called minimal residual disease, has been shown to be prognostic for progression-free and overall survival. However, for multiple myeloma, it is unclear whether patients attaining minimal residual disease negativity may be candidates for treatment discontinuation. We investigated, if longitudinal flow cytometry-based monitoring of minimal residual disease (flow-MRD) may predict disease progression earlier and with higher sensitivity compared to biochemical assessments. Methods: Patients from the Nordic countries with newly diagnosed multiple myeloma enrolled in the European-Myeloma-Network-02/Hovon-95 (EMN02/HO95) trial and undergoing bone marrow aspiration confirmation of complete response, were eligible for this Nordic Myeloma Study Group (NMSG) substudy. Longitdudinal flow-MRD assessment of bone marrow samples was performed to identify and enumerate residual malignant plasma cells until observed clinical progression. Results: Minimal residual disease dynamics were compared to biochemically assessed changes in serum free light chain and M-component. Among 20 patients, reaching complete response or stringent complete response during the observation period, and with >= 3 sequential flow-MRD assessments analysed over time, increasing levels of minimal residual disease in the bone marrow were observed in six cases, preceding biochemically assessed disease and clinical progression by 5.5 months and 12.6 months (mean values), respectively. Mean malignant plasma cells doubling time for the six patients was 1.8 months (95% CI, 1.4-2.3 months). Minimal malignant plasma cells detection limit was 4 x 10-5. Conclusions: Flow-MRD is a sensitive method for longitudinal monitoring of minimal residual disease dynamics in multiple myeloma patients in complete response. Increasing minimal residual disease levels precedes biochemically assessed changes and is an early indicator of subsequent clinical progression.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Multiple myeloma; Minimal residual disease; Flow cytometry
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Schmitz, Alexand ...
-
Brondum, Rasmus ...
-
Johnsen, Hans Er ...
-
Mellqvist, Ulf-H ...
-
Waage, Anders
-
Gimsing, Peter
-
visa fler...
-
Bruinink, Davine ...
-
van der Velden, ...
-
van der Holt, Br ...
-
Hansson, Markus
-
Andersen, Niels ...
-
Frolund, Ulf Chr ...
-
Helleberg, Carst ...
-
Schjesvold, Fred ...
-
Ahlberg, Lucia
-
Gulbrandsen, Nin ...
-
Andreasson, Bjor ...
-
Lauri, Birgitta
-
Haukas, Einar
-
Bodker, Julie St ...
-
Roug, Anne Stids ...
-
Bogsted, Martin
-
Severinsen, Mari ...
-
Gregersen, Henri ...
-
Abildgaard, Niel ...
-
Sonneveld, Piete ...
-
Dybkaer, Karen
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
BMC Cancer
- Av lärosätet
-
Linköpings universitet